Skip to content

Investigating attentional function and cognitive fluctuations in Lewy body disease

Investigating attentional function and cognitive fluctuations in Lewy body disease: a functional magnetic imaging and electrophysiology multicentre non-randomised observational diagnosis cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN97853380
Enrollment
96
Registered
2010-10-21
Start date
2010-09-01
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Dementias and Neurodegenerative Diseases Research Network

Interventions

1. Diffusion tensor imaging to assess white matter integrity 2. Functional imaging: functional magnetic resonance imaging (fMRI) BOLD brain scan in response to the attention network task 3. High densi

Sponsors

Northumbria Tyne and Wear NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. For dementia patients: that they meet defined clinical criteria for diagnosis of dementia (dementia with Lewy bodies, Parkinson's disease with dementia, or Alzheimer's dementia) and Mini-Mental State Examination (MMSE) test score of more than 12 2. For healthy controls: No history of psychiatric or neurological brain disease and MMSE score more than 26 and has capacity to consent to participate 3. All aged 60 years and above, either sex

Exclusion criteria

Exclusion criteria: 1. Contraindications for or unwillingness to undergo MR imaging 2. Severe dementia (MMSE score less than 12), as such subjects will have difficulty fully understanding the nature and extent of the proposed research 3. Presence of other severe or unstable medical illnesses 4. Subjects with a history of visual impairment secondary to glaucoma, cataract, or macular degeneration as this could affect the ability of subjects to perform the visual attention task with LBD 5. Medications: subjects on benzodiazepines, antipsychotics or anticonvulsants will not be included as these can effect the EEG activity patterns

Design outcomes

Primary

MeasureTime frame
Functional MR BOLD activations to attentional network task, measured at end of study

Secondary

MeasureTime frame
1. Diffusion tensor measures of white matter, measured at end of study 2. Spatio-temporal EEG activations to attentional network task, measured at end of study

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026